OBJECTIVE: To study propanthelin bromide efficacy in preventing vasovagal syncope relapse. SETTING: HGZ No. 3 IMSS, Mazatlán, Sinaloa, México, from 1992 to 1995. PATIENTS: 10 patients with vasovagal syncope were selected from 41 syncope patients. DESIGN: Prospective longitudinal. MEASURES: clinical charts, neurologic and cardiologic evaluation, electrocardiogram, electroencephalogram, C.A.T., Holter, stress test and chest X rays were made. In 10 patients, 15 to 30 mg of propanthelin bromide thrice a day were administered, 12 month survey on was made measured. RESULTS: Of the 10 patients, 7 were women mean age 18 years. In 9 of them no recurrence was evident abandoned 1 treatment, 4 had side effects. CONCLUSIONS: Propanthelin bromide decreases vasovagal syncope episodes with few side effects.
OBJECTIVE: To study propanthelin bromide efficacy in preventing vasovagal syncope relapse. SETTING: HGZ No. 3 IMSS, Mazatlán, Sinaloa, México, from 1992 to 1995. PATIENTS: 10 patients with vasovagal syncope were selected from 41 syncopepatients. DESIGN: Prospective longitudinal. MEASURES: clinical charts, neurologic and cardiologic evaluation, electrocardiogram, electroencephalogram, C.A.T., Holter, stress test and chest X rays were made. In 10 patients, 15 to 30 mg of propanthelin bromide thrice a day were administered, 12 month survey on was made measured. RESULTS: Of the 10 patients, 7 were women mean age 18 years. In 9 of them no recurrence was evident abandoned 1 treatment, 4 had side effects. CONCLUSIONS:Propanthelin bromidedecreases vasovagal syncope episodes with few side effects.